Sensory nerves have an essential role in bone remodeling. In particular, semaphorin 3A (Sema3A) regulates bone remodeling by modulating sensory nerve development. (posted Sept. 9, 2013)
Speak Out Rheum: Under the Radar
A physician–patient’s experience with Sjögren’s syndrome
SGR Fix Finally on the Horizon?
By a 51–0 vote, the House Energy and Commerce Committee in July passed H.R. 2810, legislation that would repeal the Sustainable Growth Rate (SGR) formula. (posted Sept. 9, 2013)
Physician Maxime Dougados, MD, Is Intent on Advancing Clinical Measurement in Rheumatology
Visionary rheumatologist credited with developing new spondylarthritis criteria, collaborating on the OASIS study, and promoting the 3E Initiative in rheumatology
Tech Talk: New Technologies Attempt to Find Better Treatments for Rheumatic Diseases
Research in proteomics and genetics sheds new light on treatment strategies, brings potential for breakthroughs
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Rheum After 5: Air Force Rheumatologist Fine-Tunes Art of Violin Making
Violin enthusiast Jay Higgs, MD, says hobby blends craftsmanship, art, history, and science of acoustics
Rheumatologists on the Move
Awards, appointments, and announcements in the world of rheumatology
EULAR 2013: Researchers Expand Targets for PsA, OA Therapy
Experts discuss insights in the pathogenesis of psoriatic arthritis and the role of subchondral bone in osteoarthritis
EULAR 2013: Drugs New and Old Could Treat Spondylarthropies
Nonsteroidal anti-inflammatory drugs (NSAIDs) might still have a role in treating axial spondylarthritis, but other drugs, therapies are being explored
- « Previous Page
- 1
- …
- 624
- 625
- 626
- 627
- 628
- …
- 796
- Next Page »